On 26 November 2021 I wrote to Toby Lasserson, Cochrane’s Deputy Editor-in-Chief, copying in in Gill Leng the Chief Executive Officer of NICE. I received a short response from Cochrane on 9 December. Today, 31 December, I wrote to Gill Leng, outgoing CEO of NICE copying in the incoming CEO of NICE, and other relevant… Continue reading Letter to Gill Leng, outgoing CEO, NICE, 31 December 2021